Eliquis 2.5 MG tablet 60S

Ended Awarded

Contract number
SPE2DX24F03CT
Awardee
Awarding agency
Obligated
$10,352

Award facts

Contract value 100% obligated
$10,351.73 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,351.73, is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a cardiovascular medication, to support military healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract award does not have a set-aside designation, indicating open competition.

Quick answers

Who was awarded contract SPE2DX24F03CT?

SPE2DX24F03CT was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 8, 2024.

How much is contract SPE2DX24F03CT worth?

The government has obligated $10,352 on SPE2DX24F03CT.

Is contract SPE2DX24F03CT an order under another contract?

Yes. SPE2DX24F03CT is a delivery order under SPE2DX15D3006, an indefinite delivery contract.

Was contract SPE2DX24F03CT competed?

The extent of competition for SPE2DX24F03CT was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award